SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

SYMBIOTECUpdated 1 Sept 2026, 17:07

Symbiotec Pharmalab Ltd

Market Cap

₹8,927Cr.

Current Price

₹1,098

High / Low

₹/

Stock P/E

61.2

Book Value
Dividend Yield%
ROCE21.1%
ROE17.4%
Face Value₹2.00

About

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days7083736885
Inventory Days309250304378309
Days Payable15186109254101
Cash Conversion Cycle228246268191293
Working Capital Days11113711010553
ROCE %12%8%16%21%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 17:07


Designed & Shipped by Harshit Bansal